Guangdong, Tianjin, China Related Funds
| Fund Name | Location |
| Amar Foundation | District of Columbia, United States, Washington |
| Asia Capital | Colombo, Sri Lanka, Western Province |
| Capital Medica Ventures | Chiyoda, Japan |
| Central Intelligence Agency (CIA) | District of Columbia, United States, Washington |
| Chengbo Investment | China, Tianjin, Tianjin |
| CitareTx Investment Partners I | Houston, Texas, United States |
| CMF Venture Capital | - |
| Co-Share capital | China, Guangdong, Guangzhou |
| Esperanza Investments Limited | - |
| Falcon Capital | England, London, United Kingdom |
| Funding Strategy Partners | Newtown, Pennsylvania, United States |
| Knockout Capital | California, Los Angeles, United States |
| Lotus | - |
| Money Forward | Chiyoda, Japan |
| New Science Ventures | New York, New York, United States |
| One World Capital | China, Shaanxi, Xian Shi |
| Promus Capital | Chicago, Illinois, United States |
| Xuwei Investment | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Huadao Biopharma | $1M | 26 Jun 2018 | Shanghai, China | ||
| $38M | 13 Dec 2017 | China, Shanghai | |||
Huadao Biopharma | $463K | 08 Nov 2017 | Shanghai, China | ||
Beijing Jingcheng Boai Rehabilitation Hospital | $1M | 09 Feb 2015 | Dongcheng District, Beijing, China | ||
Orbiepharm | $1M | 17 Mar 2014 | Haidian District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Huadao Biopharma | $1M | 26 Jun 2018 | Shanghai, China | ||
| $38M | 13 Dec 2017 | China, Shanghai | |||
Huadao Biopharma | $463K | 08 Nov 2017 | Shanghai, China | ||
Beijing Jingcheng Boai Rehabilitation Hospital | $1M | 09 Feb 2015 | Dongcheng District, Beijing, China | ||
Orbiepharm | $1M | 17 Mar 2014 | Haidian District, Beijing, China |
